KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tidewater (TDW) Asset Writedowns and Impairment (2016 - 2022)

Historic Asset Writedowns and Impairment for Tidewater (TDW) over the last 9 years, with Q3 2022 value amounting to $1.2 million.

  • Tidewater's Asset Writedowns and Impairment fell 4397.78% to $1.2 million in Q3 2022 from the same period last year, while for Jun 2023 it was $1.2 million, marking a year-over-year decrease of 9198.31%. This contributed to the annual value of $714000.0 for FY2022, which is 9543.57% down from last year.
  • Tidewater's Asset Writedowns and Impairment amounted to $1.2 million in Q3 2022, which was down 4397.78% from -$500000.0 recorded in Q1 2022.
  • Tidewater's Asset Writedowns and Impairment's 5-year high stood at $55.5 million during Q2 2020, with a 5-year trough of -$1.0 million in Q2 2021.
  • Its 5-year average for Asset Writedowns and Impairment is $11.8 million, with a median of $5.7 million in 2018.
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first surged by 1113117.41% in 2020, then crashed by 10180.24% in 2021.
  • Quarter analysis of 5 years shows Tidewater's Asset Writedowns and Impairment stood at $36.9 million in 2018, then dropped by 11.74% to $32.5 million in 2019, then plummeted by 80.11% to $6.5 million in 2020, then skyrocketed by 108.12% to $13.5 million in 2021, then tumbled by 90.99% to $1.2 million in 2022.
  • Its Asset Writedowns and Impairment was $1.2 million in Q3 2022, compared to -$500000.0 in Q1 2022 and $13.5 million in Q4 2021.